Prolonged Mechanical Ventilation Shannon S. Carson, MD Associate - - PowerPoint PPT Presentation

prolonged mechanical ventilation
SMART_READER_LITE
LIVE PREVIEW

Prolonged Mechanical Ventilation Shannon S. Carson, MD Associate - - PowerPoint PPT Presentation

Prolonged Mechanical Ventilation Shannon S. Carson, MD Associate Professor and Chief Pulmonary and Critical Care Medicine University of North Carolina AJRCCM 2010 Projected Growth of Prolonged Acute MV Zilberberg et al. Crit Care Med


slide-1
SLIDE 1

Prolonged Mechanical Ventilation

Shannon S. Carson, MD Associate Professor and Chief Pulmonary and Critical Care Medicine University of North Carolina

slide-2
SLIDE 2

AJRCCM 2010

slide-3
SLIDE 3

Projected Growth of Prolonged Acute MV

Zilberberg et al. Crit Care Med 2008;36:1451

slide-4
SLIDE 4

Outcomes of Prolonged Ventilation

Cohort Definition Ventilation for ≥14 days Ventilation for ≥21 days Tracheostomy for Prolonged Mechanical Ventilation Weaning Center Study Combes Carson Cox Engoren Rose N 347 200 114 267 347 115 Hospital Length of Stay

median (IQR)

  • 51

(36-72) 39 (30-52) 29 (22-38) 28-37 64 (35-109) Died in Hospital 43% 41% 31% 20% 22% 15% Discharged Home

  • 11%

4% 7%

  • 13%

Alive at 12 months 32% 48% 42% 52% 50% 37%

slide-5
SLIDE 5

Activities of Daily Living (ADL) scores

1 2 3 4 5 6

  • 2

2 4 6 8 10 12

Follow-Up, Months PMV non-PMV

p = 0.04 between groups p = 0.0001 for time trend

Cox et al. Crit Care 2007.

slide-6
SLIDE 6

Brain Dysfunction in PMV

  • Prospective cohort 203 patients from Respiratory

Care Unit

  • Nelson et al. Arch Intern Med 2006;166:1993

– 82% cognitively intact at baseline – 30% comatose throughout RCU stay – 50% non-coma patients delirious

  • 6 month follow-up

– 71% of survivors too cognitively impaired for tel. testing – Remaining 25% cognitively intact (30 patients)

slide-7
SLIDE 7

Management

Prevent Complications Maximize Function Communicate Prognosis/Goals of Care

slide-8
SLIDE 8

Preventing Infections

  • Prevent Ventilator Associated Pneumonias

– HOB elevation – Remove NG tubes – Avoid gastric distension – Chlorhexadine mouth rinses? – Avoid sedatives, narcotics when possible

  • Prevent Central Line Related Bloodstream Infections

– D/C unnecessary lines!!! – Checklist – Full drapes – Line Cart

slide-9
SLIDE 9

Infection Control in PMV

  • High threshold for broad spectrum antibiotics

– Treat sepsis aggressively – Confirm infection before treating isolated fever

  • VAP – BAL/mini-BAL/Quantitative trach aspirate

– Tracheobronchitis—be appropriately conservative

  • Bladder infections

– SIRS and Pyuria – Positive culture with no other apparent source

  • Know local ‘Antibiograms’
slide-10
SLIDE 10

Maximize Function

slide-11
SLIDE 11

Nutrition

  • Avoid Overfeeding

– Volume expansion, hyperglycemia, steatocholestasis, increased ventilatory load

  • McClave et al. J Parent Enteral Nutr. 1998;22:375

– 213 PMV patients from 32 hospitals – Indirect calorimetry measurements – 58.2% of patients receiving >110% of required calories – 12.2% were being underfed

  • 20-25 kcal/kg/day
  • Enteral and parenteral feeding?

– Hollander, Mechanick. Nutr Clin Pract. Dec 2006;21(6):587

slide-12
SLIDE 12

Pressure Ulcers

  • Prevention

– Turning, Specialty Beds, Cleaning – Early Mobilization

  • Management

– Debridement – Wet-to-dry dressings – Wound Vac? – Judicious use of antibiotics – Specialist Care

slide-13
SLIDE 13

Mobility – Barriers or Excuses?

– Limitations in cardiovascular and respiratory reserve – Bleeding risks – Cognitive function – Orthopedic issues, wounds – Attachments, Devices – Obesity

  • Solution:

– Mobility Team

  • Morris et al. Crit Care Med 2006; 34:A20

– Adaptation of traditional roles

  • Physiotherapist model
  • Hopkins Crit Care Clinics 2007;23:81
slide-14
SLIDE 14

Delirium Risk

  • Age
  • Baseline dementia
  • Underlying illness

– Inflammation – Coagulation

  • Metabolic Disturbances
  • Hypoxemia, hypercarbia
  • Psychoactive Medications
  • Sleep Deprivation

Inouye, JAMA 1996;275:852-57 Dubois, Intens Care Med 2001;27:1297-1304 Inouye, NEJM 1999;340:669-676 Jacobi, Crit Care Med 2002;30:119-141 Milbrandt, Crit Care Med. 2005;33:226-9

slide-15
SLIDE 15

Psychological Support

  • Prevent delirium
  • Early mobility
  • Communication

– Speaking valve

  • Oral feeding
  • Careful treatment of pain and anxiety
  • Depression

– Extremely common

  • Jubran Intensive Care Med. May 2010;36(5):828

– Antidepressants work slowly – Methylphenidate

  • Woods et al. J Clin Psychol 1986; 47:12
slide-16
SLIDE 16

Dedicated Units for PMV Patients

  • Multidisciplinary Rehabilitation Approach
  • Specialization within disciplines

– RT, Nutrition, PT

  • Protocolized care
  • Lower nursing intensity; less monitoring

– Lower costs??

  • Short-term acute care hospital models
  • Long-term care hospital (LTCH) models
slide-17
SLIDE 17

LTAC vs Acute Costs for PMV

  • LTCH patients and non-LTCH patients matched based upon propensity for LTCH

referral

  • 68 days in episode with LTCH care vs 45.8 days without LTCH care
  • www.rti.org/reports/cms
  • Differences in episode payments and costs relative to non-LTCH patient with low

likelihood of LTCH referral (lower left point on graphs)

slide-18
SLIDE 18

Unroe et al. Ann Intern Med 2010; 153;167.

slide-19
SLIDE 19

Unroe et al. Ann Intern Med 2010; 153;167

slide-20
SLIDE 20

0.00 0.25 0.50 0.75 1.00 200 400 600 800 1000 Days Since Enrollment Score = 0 Score = 1 Score = 2 Score = 3 Score = 4 or 5

Survival by ProVent Score

Age >65 - 2 points Platelets <150 - 1 point Age 50-65 - 1 point Vasopressors - 1 point Dialysis - 1 point Area under ROC 0.79 (95% CI, 0.75, 0.81) Hosmer Lemeshow GoF p=0.89

Day 21 of MV

Crit Care Med 2012; 40:1171-1176

slide-21
SLIDE 21

Summary

  • Managing the complications of PMV should be

considered within the context of improving functional

  • utcomes as well as survival
  • Infections are the most common cause of death in PMV

and are often preventable

  • Prolonged physical limitations should be prevented with

early mobility, wound prevention, and nutrition

  • Care venues should be selected based upon patient

needs, but are often determined by resources

  • Tools are available to improve understanding and

communication of prognosis/goals of care

slide-22
SLIDE 22

Survival of LTCH PMV Patients

slide-23
SLIDE 23

Discordance

High Expectations For: Surrogates (%) Physicians (%) One-year Survival 93 43 Functional Status 71 6 Quality of Life 83 4 Concordance: κ = 0.08

Cox Crit Care Med 2009;37:2891